MX2019002552A - Composition comprising multivalent capsular polysaccharide-transp ort protein and use thereof. - Google Patents

Composition comprising multivalent capsular polysaccharide-transp ort protein and use thereof.

Info

Publication number
MX2019002552A
MX2019002552A MX2019002552A MX2019002552A MX2019002552A MX 2019002552 A MX2019002552 A MX 2019002552A MX 2019002552 A MX2019002552 A MX 2019002552A MX 2019002552 A MX2019002552 A MX 2019002552A MX 2019002552 A MX2019002552 A MX 2019002552A
Authority
MX
Mexico
Prior art keywords
composition
capsular polysaccharide
protein
multivalent
transp
Prior art date
Application number
MX2019002552A
Other languages
Spanish (es)
Inventor
Hyun Kim Tae
Sung Jeh Hoon
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MX2019002552A publication Critical patent/MX2019002552A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Abstract

The present invention relates to a vaccine composition comprising 13 or 14 kinds of capsular polysaccharide-transport protein conjugates for prevention of pneumococcal diseases and an immunogenic composition for Streptococcus pneumoniae.
MX2019002552A 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transp ort protein and use thereof. MX2019002552A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Publications (1)

Publication Number Publication Date
MX2019002552A true MX2019002552A (en) 2019-07-01

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002552A MX2019002552A (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transp ort protein and use thereof.

Country Status (12)

Country Link
KR (1) KR101991457B1 (en)
BR (1) BR112019004303A2 (en)
EA (1) EA201990451A1 (en)
JO (1) JOP20190038B1 (en)
MA (1) MA45283B1 (en)
MX (1) MX2019002552A (en)
MY (1) MY192792A (en)
PH (1) PH12019500377A1 (en)
SA (1) SA519401232B1 (en)
TN (1) TN2019000064A1 (en)
WO (1) WO2018048141A1 (en)
ZA (1) ZA201901969B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3084436A1 (en) 2017-12-06 2019-07-18 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
BR112020015696A2 (en) 2018-02-05 2020-12-08 Sanofi Pasteur, Inc. COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACARID-PROTEIN CONJUGATE
CN111989114A (en) 2018-04-18 2020-11-24 Sk生物科学株式会社 Capsular polysaccharides of streptococcus pneumoniae and immunogenic conjugates thereof
AU2019401535B2 (en) 2018-12-19 2023-12-14 Merck Sharp & Dohme Llc Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2023218322A1 (en) * 2022-05-11 2023-11-16 Pfizer Inc. Process for producing of vaccine formulations with preservatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU678613B2 (en) * 1993-09-22 1997-06-05 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
KR101730748B1 (en) * 2005-04-08 2017-04-26 와이어쓰 엘엘씨 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN102933229A (en) * 2010-06-04 2013-02-13 惠氏有限责任公司 Vaccine formulations
KR102057217B1 (en) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN103893751B (en) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 A kind of pneumococal polysaccharide Protein Conjugation vaccine and preparation method thereof
CN104069504B (en) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 A method of enhancing polysaccharide protein conjugate immunogenicity

Also Published As

Publication number Publication date
KR101991457B1 (en) 2019-09-30
SA519401232B1 (en) 2022-10-23
MY192792A (en) 2022-09-09
ZA201901969B (en) 2019-12-18
PH12019500377A1 (en) 2019-10-21
EA201990451A1 (en) 2019-08-30
MA45283A1 (en) 2019-06-28
BR112019004303A2 (en) 2019-05-28
MA45283B1 (en) 2021-05-31
JOP20190038B1 (en) 2023-09-17
KR20180027353A (en) 2018-03-14
WO2018048141A1 (en) 2018-03-15
TN2019000064A1 (en) 2020-07-15
JOP20190038A1 (en) 2019-03-06

Similar Documents

Publication Publication Date Title
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PH12019500377A1 (en) Composition comprising multivalent capsular polysaccharide-transport protein and use thereof
IL297575B1 (en) Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
MX2022014850A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
MX2022009928A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
MX2022009927A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
BR112016015835A2 (en) CAPSULAR POLYSACCHARIDES FROM STREPTOCOCCUS PNEUMONIAE AND CONJUGATES THEREOF
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2017009308A (en) Immunogenic compositions for use in pneumococcal vaccines.
EP3668541A4 (en) Pneumococcal conjugate vaccine formulations
EP3585803A4 (en) Pneumococcal conjugate vaccine formulations
MX2020002555A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
MX2019008564A (en) Immunogenic compositions for use in pneumococcal vaccines.
EP3863667A4 (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine
PH12018501205A1 (en) Synthetic vaccines against streptococcus pneumoniae serotype 2
SG11201911757WA (en) Novel multivalent polysaccharide - protein conjugate vaccine composition and formulation thereof